StockNews.com Initiates Coverage on China Pharma (NYSE:CPHI)

StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI) in a research report issued on Friday. The firm set a “hold” rating on the stock.

China Pharma Price Performance

NYSE CPHI opened at $0.26 on Friday. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.26 and a current ratio of 0.79. The company has a 50-day simple moving average of $0.22 and a two-hundred day simple moving average of $0.22. China Pharma has a 12-month low of $0.13 and a 12-month high of $0.44.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.